Patents by Inventor Jeffrey Saunders

Jeffrey Saunders has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12146576
    Abstract: A piston for a pressure-reducing valve includes a tubular housing having an internal longitudinal bore extending from a first end to a second end. An exterior circumferential sealing disc sealing engages internal walls. The sealing disc has upper and lower faces generally perpendicular to a longitudinal axis. First fluid port(s) and second fluid port(s) extend through the tubular housing and into the longitudinal bore. A piston stem sealingly engages an internal surface of the longitudinal bore between the sealing disc and the second end to prevent the passage of fluid. The piston stem, together with a portion of the longitudinal bore, forms fluid passageway(s) that fluidly connect the first fluid port(s) with the second fluid port(s). The second fluid port(s) are inclined relative to the longitudinal axis and extend through at least a portion of the sealing disc, intersecting at least a portion of the upper face thereof.
    Type: Grant
    Filed: May 3, 2023
    Date of Patent: November 19, 2024
    Assignee: PALAMAR INDUSTRIES INC.
    Inventors: Jeffrey Saunders, William Palamar
  • Publication number: 20230358334
    Abstract: A piston for a pressure-reducing valve includes a tubular housing having an internal longitudinal bore extending from a first end to a second end. An exterior circumferential sealing disc sealing engages internal walls. The sealing disc has upper and lower faces generally perpendicular to a longitudinal axis. First fluid port(s) and second fluid port(s) extend through the tubular housing and into the longitudinal bore. A piston stem sealingly engages an internal surface of the longitudinal bore between the sealing disc and the second end to prevent the passage of fluid. The piston stem, together with a portion of the longitudinal bore, forms fluid passageway(s) that fluidly connect the first fluid port(s) with the second fluid port(s). The second fluid port(s) are inclined relative to the longitudinal axis and extend through at least a portion of the sealing disc, intersecting at least a portion of the upper face thereof.
    Type: Application
    Filed: May 3, 2023
    Publication date: November 9, 2023
    Inventors: Jeffrey Saunders, William Palamar
  • Patent number: 10453351
    Abstract: An automated detection and avoidance system that provides a pilot with high-fidelity knowledge of the aircraft's physical state, and notifies the pilot of any deviations in expected state based on predictive models. The automated detection and avoidance system may include a processor and a sensor payload operatively coupled to the processor to detect a non-cooperative obstacle within a first airspace adjacent the aircraft. The sensor payload may comprise a radar to radially scan the first airspace, and a camera to scan a second airspace within said first airspace.
    Type: Grant
    Filed: July 17, 2017
    Date of Patent: October 22, 2019
    Assignee: Aurora Flight Sciences Corporation
    Inventors: Jae-Woo Choi, Jeffrey Saunders, James D. Paduano
  • Publication number: 20190019423
    Abstract: An automated detection and avoidance system that provides a pilot with high-fidelity knowledge of the aircraft's physical state, and notifies the pilot of any deviations in expected state based on predictive models. The automated detection and avoidance system may include a processor and a sensor payload operatively coupled to the processor to detect a non-cooperative obstacle within a first airspace adjacent the aircraft. The sensor payload may comprise a radar to radially scan the first airspace, and a camera to scan a second airspace within said first airspace.
    Type: Application
    Filed: July 17, 2017
    Publication date: January 17, 2019
    Inventors: Jae-Woo Choi, Jeffrey Saunders, James D. Paduano
  • Patent number: 9379228
    Abstract: A heterojunction semiconductor field effect transistor HFET having a pair of layers of different semiconductor materials forming a quantum well within the structure to support the 2DEG. Source, drain and gate electrodes are disposed above the channel. The HFET has a predetermined transconductance. A transconductance control electrode varies an electric field within the structure under the channel to vary the shape of the quantum well and thereby the transconductance of the FET in accordance with a variable control signal fed to the transconductance control electrode.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: June 28, 2016
    Assignee: RAYTHEON COMPANY
    Inventors: Jeffrey Saunders, Shahed Reza, Eduardo M. Chumbes
  • Publication number: 20160149022
    Abstract: A heterojunction semiconductor field effect transistor HFET having a pair of layers of different semiconductor materials forming a quantum well within the structure to support the 2DEG. Source, drain and gate electrodes are disposed above the channel. The HFET has a predetermined transconductance. A transconductance control electrode varies an electric field within the structure under the channel to vary the shape of the quantum well and thereby the transconductance of the FET in accordance with a variable control signal fed to the transconductance control electrode.
    Type: Application
    Filed: November 20, 2014
    Publication date: May 26, 2016
    Applicant: RAYTHEON COMPANY
    Inventors: Jeffrey Saunders, Shahed Reza, Eduardo M. Chumbes
  • Patent number: 9115086
    Abstract: Compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.
    Type: Grant
    Filed: December 29, 2011
    Date of Patent: August 25, 2015
    Assignee: AGIOS PHARMACEUTICALS, INC.
    Inventors: Francesco G. Salituro, Jeffrey Saunders
  • Patent number: 8889667
    Abstract: Compounds and compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.
    Type: Grant
    Filed: December 29, 2011
    Date of Patent: November 18, 2014
    Assignee: Agios Pharmaceuticals, Inc
    Inventors: Francesco G. Salituro, Jeffrey Saunders, Shunqi Yan
  • Publication number: 20130184222
    Abstract: Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1 comprising administering to a subject in need thereof a compound described here.
    Type: Application
    Filed: July 15, 2011
    Publication date: July 18, 2013
    Applicant: AGIOS PHARMACEUTICALS, INC
    Inventors: Janeta Popovici-Muller, Francesco G. Salituro, Jeffrey Saunders, Jeremy Travins, Shunqi Yan
  • Publication number: 20120172349
    Abstract: Compounds and compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.
    Type: Application
    Filed: December 29, 2011
    Publication date: July 5, 2012
    Inventors: Francesco G. Salituro, Jeffrey Saunders, Shunqi Yan
  • Publication number: 20120165324
    Abstract: Compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.
    Type: Application
    Filed: December 29, 2011
    Publication date: June 28, 2012
    Inventors: Francesco G. Salituro, Jeffrey Saunders
  • Publication number: 20070270473
    Abstract: Compounds that modulate GHS-R are described, for examples compounds formula (I)
    Type: Application
    Filed: November 29, 2006
    Publication date: November 22, 2007
    Inventors: Jeffrey Saunders, Thomas Coulter, Paul Mortenson, Manuel Navia, Jean-Francois Pons
  • Publication number: 20070139108
    Abstract: A pre-distorter that compensates for amplitude and phase distortion created by an amplifier. During a training session, the amplifier is stimulated with input signals of pre-selected amplitude and phase at various temperatures and the amplifier output is captured and converted into data sets. Polynomials are then fitted to the data sets and inverses of the polynomials are determined. The coefficients of the inverse polynomials are then saved for each temperature. During operation, the amplifier temperature is predicted based on the amplifier input signal and the coefficients associated with the predicted temperature are selected to be applied to the input signal to compensate for amplitude and phase distortion caused by the amplifier.
    Type: Application
    Filed: February 7, 2007
    Publication date: June 21, 2007
    Inventors: Mohammad Mobin, Jeffrey Saunders, Lane Smith
  • Publication number: 20060293370
    Abstract: Compounds that modulate GHS-R are described, for examples compounds formula (I)
    Type: Application
    Filed: June 12, 2006
    Publication date: December 28, 2006
    Inventors: Jeffrey Saunders, Thomas Coulter, Paul Mortenson, Manuel Navia, Jean-Francois Pons
  • Patent number: 7087642
    Abstract: The present invention relates to compounds which inhibit IMPDH. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting IMPDH enzyme activity and consequently, may be advantageously used as therapeutic agents for IMPDH-mediated processes. This invention also relates to methods for inhibiting the activity of IMPDH using the compounds of this invention and related compounds.
    Type: Grant
    Filed: November 4, 2002
    Date of Patent: August 8, 2006
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Dean Stamos, Martin Trudeau, Scott Bethiel, Steven Ronkin, Michael Badia, Jeffrey Saunders
  • Publication number: 20060033569
    Abstract: A pre-distorter that compensates for amplitude and phase distortion created by an amplifier. During a training session, the amplifier is stimulated with input signals of pre-selected amplitude and phase at various temperatures and the amplifier output is captured and converted into data sets. Polynomials are then fitted to the data sets and inverses of the polynomials are determined. The coefficients of the inverse polynomials are then saved for each temperature. During operation, the amplifier temperature is predicted based on the amplifier input signal and the coefficients associated with the predicted temperature are selected to be applied to the input signal to compensate for amplitude and phase distortion caused by the amplifier.
    Type: Application
    Filed: August 16, 2004
    Publication date: February 16, 2006
    Inventors: Mohammad Mobin, Jeffrey Saunders, Lane Smith
  • Publication number: 20050282876
    Abstract: The present invention relates to a novel class of compounds which are IMPDH inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting IMPDH enzyme activity and consequently, may be advantageously used as therapeutic agents for IMPDH mediated processes. This invention also relates to methods for inhibiting the activity of IMPDH using the compounds of this invention and related compounds.
    Type: Application
    Filed: July 29, 2005
    Publication date: December 22, 2005
    Inventors: David Armistead, Michael Badia, Guy Bemis, Randy Bethiel, Catharine Frank, Perry Novak, Steven Ronkin, Jeffrey Saunders
  • Publication number: 20050261332
    Abstract: Compounds of formulas (I), (II), (III), and (IV) and methods of treating disorders by administering a compound of formula (I), (II), (III), or (IV) are described herein. Examples of disorders include neoplastic disorders, fat-cell related disorders, neurodegenerative disorders, and metabolic disorders.
    Type: Application
    Filed: April 4, 2005
    Publication date: November 24, 2005
    Inventors: Peter Distefano, Andrew Napper, Rory Curtis, Jay Luly, Jean-Francois Pons, Russell Thomas, Manuel Navia, Thomas Coulter, Jeffrey Saunders, Bard Geesaman
  • Publication number: 20050231279
    Abstract: A predistorter is disclosed that predistorts an input signal based on one or more static coefficients that are representative of a non-linear distortion characteristic of an amplifier. The input signal is also processed based on a non-linear gain parameter that reduces an error metric between the input signal and a feedback signal. The nonlinear gain parameter adapts an amount of nonlinearity introduced by the predistorter. The non-linear gain adaptation is performed, for example, when the input voltage is above a threshold input voltage. The input signal can be processed by multiplying the input signal by the non-linear gain parameter followed by table-coefficient processing, or by both multiplying the input by the non-linear gain parameter followed by dividing the table-coefficient processed output signal by the same non-linear gain parameter. The input signal can also be processed based on a feedback gain parameter that compensates for a small-signal gain of the feedback loop.
    Type: Application
    Filed: April 15, 2004
    Publication date: October 20, 2005
    Inventors: James Moffatt, Jeffrey Saunders
  • Publication number: 20050187237
    Abstract: Compounds of formula (I) are described herein The compounds can be used, for example, to modulate growth hormone secretagogue receptor (GHS-R). In some instances, the compounds can be used to treat obesity.
    Type: Application
    Filed: November 4, 2004
    Publication date: August 25, 2005
    Inventors: Peter Distefano, Andrew Napper, Rory Curtis, Jay Luly, Manuel Navia, Russell Thomas, Jean-Francois Pons, Jeffrey Saunders